ANIKA THERAPEUTICS INC (ANIK)
US0352551081 - Common Stock
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
BEDFORD, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
Announcing the limited market release of X-Twist™ Fixation System with biocomposite suture anchor for rotator cuff and other soft tissue repair at AAOS ...
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic...
Anika to Participate in Upcoming Investor Conferences
Anika to Participate in Upcoming Investor Conferences
BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Therapeutics Non-GAAP EPS of $0.00 beats by $0.35, revenue of $41.5M beats by $3.23M (NASDAQ:ANIK)
Anika Therapeutics beats expectations with Q3 earnings, reporting a non-GAAP EPS of $0.00 and revenue of $41.5M, exceeding estimates by $0.35 and $3.23M...
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management...
Commit To Buy Anika Therapeutics At $15, Earn 7.1% Annualized Using Options
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative...
Anika Therapeutics is Now Oversold (ANIK)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
BEDFORD, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
3 Sorry Penny Stocks to Sell in August Before It’s Too Late
As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail.
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure,...
Anika Reports Second Quarter 2023 Financial Results
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date...
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...